These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11256683)

  • 1. The use of nimodipine in the treatment of mood disorders.
    Goodnick PJ
    Bipolar Disord; 2000 Sep; 2(3 Pt 1):165-73. PubMed ID: 11256683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimodipine treatment of an adolescent with ultradian cycling bipolar affective illness.
    Davanzo PA; Krah N; Kleiner J; McCracken J
    J Child Adolesc Psychopharmacol; 1999; 9(1):51-61. PubMed ID: 10357518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine increases CSF somatostatin in affectively ill patients.
    Pazzaglia PJ; George MS; Post RM; Rubinow DR; Davis CL
    Neuropsychopharmacology; 1995 Aug; 13(1):75-83. PubMed ID: 8526973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nimodipine in treatment of bipolar disorder].
    Romanov DV; Sheyanov AM; Samsonova MD; Iuzbashian PG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12):20-26. PubMed ID: 38147378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low CSF somatostatin associated with response to nimodipine in patents with affective illness.
    Frye MA; Pazzaglia PJ; George MS; Luckenbaugh DA; Vanderham E; Davis CL; Rubinow DR; Post RM
    Biol Psychiatry; 2003 Jan; 53(2):180-3. PubMed ID: 12547475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation.
    Pazzaglia PJ; Post RM; Ketter TA; George MS; Marangell LB
    Psychiatry Res; 1993 Dec; 49(3):257-72. PubMed ID: 8177920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy.
    Yingling DR; Utter G; Vengalil S; Mason B
    Am J Obstet Gynecol; 2002 Dec; 187(6):1711-2. PubMed ID: 12501088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel antagonists for the treatment of bipolar disorder.
    Levy NA; Janicak PG
    Bipolar Disord; 2000 Jun; 2(2):108-19. PubMed ID: 11252650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Singh A; Verma P; Balaji G; Samantaray S; Mohanakumar KP
    Neurochem Int; 2016 Oct; 99():221-232. PubMed ID: 27395789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do calcium antagonists have a place in the treatment of mood disorders?
    Höschl C
    Drugs; 1991 Nov; 42(5):721-9. PubMed ID: 1723370
    [No Abstract]   [Full Text] [Related]  

  • 11. Nimodipine: test your drug IQ.
    Devlin MM
    Nursing; 2008 Jul; 38(7):56cc1-2. PubMed ID: 18580671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid cycling bipolar disease: new concepts and treatments.
    Dubovsky SL
    Curr Psychiatry Rep; 2001 Dec; 3(6):451-62. PubMed ID: 11707158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
    Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
    Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open trial of a calcium antagonist, nimodipine, in acute mania.
    Brunet G; Cerlich B; Robert P; Dumas S; Souetre E; Darcourt G
    Clin Neuropharmacol; 1990 Jun; 13(3):224-8. PubMed ID: 2192795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of calcium channel blockers in the treatment of affective disorders and pathologic drive for alcohol in patients with alcoholism in the remission period].
    Krupitskiĭ EM; Burakov AM; Priputina LS; Vostrikov VV; Romanova TN; Karandashova GF; Slavina TIu; Grinenko AIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(7):50-3. PubMed ID: 15347035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice.
    Zapater P; Javaloy J; Román JF; Vidal MT; Horga JF
    Brain Res; 1998 Jun; 796(1-2):311-4. PubMed ID: 9689485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorder.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):35-47. PubMed ID: 30558453
    [No Abstract]   [Full Text] [Related]  

  • 18. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.
    Pazzaglia PJ; Post RM; Ketter TA; Callahan AM; Marangell LB; Frye MA; George MS; Kimbrell TA; Leverich GS; Cora-Locatelli G; Luckenbaugh D
    J Clin Psychopharmacol; 1998 Oct; 18(5):404-13. PubMed ID: 9790159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimodipine, a dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis caused by chronic intragastric ethanol exposure in the rat.
    Iimuro Y; Ikejima K; Rose ML; Bradford BU; Thurman RG
    Hepatology; 1996 Aug; 24(2):391-7. PubMed ID: 8690410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of the preparation Nimotop in neurosurgical patients].
    Amcheslavskiĭ VG; Demchuk ML; Madorskiĭ SV; Toma GI; Margishvili GM; Fokin MS; Savin IA
    Zh Vopr Neirokhir Im N N Burdenko; 1997; (3):41-3. PubMed ID: 9424955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.